Healthcare
MultiPlan to go public in merger With Churchill Capital entity
MultiPlan’s platform is used by insurance companies to find cost savings in health-care claims
Coronavirus hotspots should consider rolling back reopening: Johns Hopkins doctor
Dr. Tom Inglesby of Johns Hopkins University said the U.S. is seeing a "really serious" surge in coronavirus cases that has caused an increase in the country's death toll.
COVID-19 heroes must jump through hoops for workers’ comp
Essential workers during coronavirus have no guarantee they will qualify for workers' compensation.
India's Biocon secures approval use drug on coronavirus patients
India’s Biocon Ltd has received regulatory approval for its drug Itolizumab to be used on coronavirus infected patients suffering from moderate to severe respiratory distress, the biopharmaceutical company said in a statement on Saturday.
Bill Gates calls for COVID-19 meds to go to people who need them, not 'highest bidder'
Billionaire philanthropist Bill Gates called for COVID-19 drugs and an eventual vaccine to be made available to countries and people that need them most, not to the “highest bidder,” saying relying on market forces would prolong the deadly pandemic.
Lemonade CFO: Catering to millennials who are used to purchasing on their phones
Lemonade CFO Tim Bixby discusses being an insurance company catering to millennials, recently going public and attempting to increase transparency and speed in the insurance industry.
Gilead says additional data on remdesivir shows improved clinical recovery
Gilead Sciences Inc said on Friday additional data from a late-stage study showed its antiviral remdesivir significantly improved clinical recovery and reduced the risk of death in COVID-19 patients.
German biotech firm says its coronavirus vaccine will be ready for approval by December
BioNTech has partnered with Pfizer to develop a coronavirus vaccine that may be ready by the end of 2020.
Trump addressing prescription drug prices, will sign executive orders
White House Chief of Staff Mark Meadows said Thursday that President Trump will issue three executive orders on prescription drug prices.
Gilead launches clinical trial of coronavirus-fighting remdesivir inhaled version
Early studies of the intravenous version of remdesivir showed the drug hastened recovery for patients hospitalized with COVID-19.
Chelsea Clinton forming venture capital firm: Report
Chelsea Clinton is showing interest in starting a venture capital firm called Metrodora Ventures, according to a report.
Coronavirus prompts double-digit weight gain for Americans under lockdown
More than three-quarters of Americans have gained weight under coronavirus lockdown, according to a new study.
Walgreens loses $1.7B as coronavirus snarls overseas sales
Walgreens Boots Alliance lost $1.7 billion in its fiscal third quarter as the coronavirus caused a sharp drop in sales.
Americans coronavirus face testing delays as virus surges
Testing has been ramped up nationwide, reaching about 640,000 tests per day on average
What is Joe Biden’s health care plan?
Democratic presidential candidate Joe Biden said he would create a public option, reduce the age for Medicare eligibility, crack down on surprise billing, and reform prescription drug pricing as part of his health care plan.
Biden’s big Medicare change may render Americans eligible sooner
A task force released proposals on Wednesday that will be submitted to the Democratic National Committee.